logo

Shariah compliance overview

Not Halal

Aardvark Therapeutics, Inc. Common Stock (AARD) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Aardvark Therapeutics, Inc. Common Stock

Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders.

Aardvark Therapeutics, Inc. Common Stock (AARD) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.

Business Activity
100.00%Limit 5%Fail
Interest-bearing debt
0.00%Limit 30%Pass
Interest-bearing securities and assets
42.86%Limit 30%Fail
Dividend purification
100.00%Share of dividends to give to charityPurification calculator

Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Aardvark Therapeutics, Inc. Common Stock (AARD). Current Akinda screening label: Not Halal.